First-Class Prostate Cancer Care
Learn How to Refer by Phone, Fax or Web.
We’ve made the first step to navigating treatment stress-free.
City of Hope has a “bench to bedside” approach that is unlike any other cancer center. We enroll patients in lifesaving clinical trials and conduct leading-edge research on the early diagnosis and screening, prevention, health disparities, risk factors and quality-of-life issues involving treatment.
Our Program Highlights
- Most robotic surgery experience in the Western United States
- Leading experts in da Vinci computer-enhanced minimally invasive surgery
- Offering outpatient robotic surgery
- Collaboration with precision medicine, such as genetic counseling and genomic testing
- Multidisciplinary care and coordination, including genetic evaluation
- mpMRI and Fusion prostate biopsy to enhance tumor detection and personalize treatment plans
- Televideo or in-person appointments scheduled within five to seven days
- A five-year survival rate close to 100% and superior outcomes for stages 1-4
- Clinical trials that aim to improve prostate cancer outcomes across the spectrum of the disease, from early to late stage
Meet Our Prostate Cancer Program Leaders
Tanya Barauskas Dorff, M.D., is a medical oncologist and professor in the Department of Medical Oncology & Therapeutics Research.
Clayton Lau, M.D., is the Director of the Prostate Cancer Program for City of Hope's Comprehensive Cancer Center in the Los Angeles region. He is also the Pauline & Martin Collins Family Chair in Urology and a top-ranked urologic surgeon.
City of Hope commits to extending whole-patient care and world-class resources to the communities we serve by accepting Medi-Cal, Medicare and many insurance plans. Our financial counselors can help you understand the financial aspects of your treatment, including your insurance and payment options.